Literature DB >> 14762223

Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases.

K Saito1, S Nakayamada, K Nakano, M Tokunaga, S Tsujimura, K Nakatsuka, T Adachi, Y Tanaka.   

Abstract

OBJECTIVES: We evaluated the polymerase chain reaction (PCR) detection of Pneumocystis carinii DNA in induced sputum of patients with connective tissue diseases and assessed the clinical features of patients positive for P. carinii.
METHODS: Sputum was induced by nebulization in 29 in-patients with various connective tissue diseases who presented with symptoms suggestive of P. carinii pneumonia (PCP), and was examined by PCR.
RESULTS: Detection of P. carinii DNA by PCR was significantly more sensitive than cytology; 54.5% patients were positive by PCR and only 4.5% by cytology. The prevalence of PCP was higher than previously considered and was especially high in patients receiving > 30 mg/day prednisolone with or without other immunosuppressants. P. carinii-positive patients had significant lymphocytopenia and a low serum IgG level compared with P. carinii-negative patients. P. carinii disappeared within 7-10 days after therapy with trimethoprim/sulfamethoxazole.
CONCLUSION: We propose that the use of PCR for detection of P. carinii using induced sputum is a useful and non-invasive method that has high sensitivity and specificity for the early diagnosis of PCP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14762223     DOI: 10.1093/rheumatology/keh071

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  10 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

Review 2.  [Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review].

Authors:  B Bertisch; C Ruef
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

3.  Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases.

Authors:  Yoko Aoki; Masahiro Iwamoto; Yasuyuki Kamata; Takao Nagashima; Taku Yoshio; Hitoaki Okazaki; Seiji Minota
Journal:  Rheumatol Int       Date:  2009-01-14       Impact factor: 2.631

4.  Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis.

Authors:  C Lahiff; O B Khiaron; N Nolan; G A Chadwick
Journal:  Ir J Med Sci       Date:  2007-09-29       Impact factor: 1.568

5.  Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases.

Authors:  Yongfeng Zhang; Yi Zheng
Journal:  Rheumatol Int       Date:  2014-06-20       Impact factor: 2.631

6.  Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes.

Authors:  Yasufumi Matsumura; Yuichiro Shindo; Yoshitsugu Iinuma; Masaki Yamamoto; Michinori Shirano; Aki Matsushima; Miki Nagao; Yutaka Ito; Shunji Takakura; Yoshinori Hasegawa; Satoshi Ichiyama
Journal:  BMC Infect Dis       Date:  2011-03-25       Impact factor: 3.090

Review 7.  Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-06

8.  Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases.

Authors:  Yuichi Ishikawa; Kazuhisa Nakano; Kei Tokutsu; Hiroko Miyata; Yoshihisa Fujino; Shinya Matsuda; Yoshiya Tanaka
Journal:  RMD Open       Date:  2021-03

9.  Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing.

Authors:  Jia Li; Jun Li; Yuetian Yu; Rongsheng Wang; Mi Zhou; Liangjing Lu
Journal:  Rheumatol Adv Pract       Date:  2021-12-27

Review 10.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.